Effect of ticagrelor versus clopidogrel after implantation of drug-eluting stents guided by either intravascular ultrasound or angiography in patients with acute coronary syndrome—propensity score matching analysis

[1] Wallentin L(2009)Ticagrelor versus Clopidogrel in patients with Acute Coronary syndromes N Engl J Med 361 1045-57

[2] Becker RC(2022)Comparison of clinical outcomes between Ticagrelor and Clopidogrel in Acute Coronary Syndrome: a Comprehensive Meta-Analysis Front Cardiovasc Med 74 93-8

[3] Budaj A(2019)Is ticagrelor worth its high cost and side-effects? Acta Cardiol 9 e015990-70

[4] Cannon CP(2022)Ticagrelor vs. Clopidogrel in older patients with Acute Coronary Syndrome undergoing percutaneous coronary intervention: insights from a Real-World Registry Front Cardiovasc Med 129 463-90

[5] Emanuelsson H(2020)Ticagrelor is not superior to clopidogrel in patients with acute coronary syndromes undergoing pci: a report from Swedish coronary angiography and angioplasty registry J Am Heart Assoc 13 1880-37

[6] Held C(2014)Relationship between intravascular ultrasound guidance and clinical outcomes after drug-eluting stents: the assessment of dual antiplatelet therapy with drug-eluting stents (ADAPT-DES) study Circulation 11 e023481-70

[7] Sun M(2020)Long-term outcomes of coronary stenting with and without Use of Intravascular Ultrasound JACC Cardiovasc Interv 72 3126-47

[8] Cui W(2022)Role of Intravascular Ultrasound-guided percutaneous coronary intervention in optimizing outcomes in Acute Myocardial Infarction J Am Heart Assoc 62 1563-64

[9] Li L(2018)Intravascular Ultrasound Versus Angiography-guided drug-eluting stent implantation: the ULTIMATE Trial J Am Coll Cardiol 123 2736-367

[10] Guerbaai RA(2013)Consideration of a new definition of clinically relevant Myocardial Infarction after coronary revascularization: an expert consensus document from the Society for Cardiovascular Angiography and interventions (SCAI) J Am Coll Cardiol 31 2755-165

[1] Wallentin L(2009)Ticagrelor versus Clopidogrel in patients with Acute Coronary syndromes N Engl J Med 361 1045-57

[2] Becker RC(2022)Comparison of clinical outcomes between Ticagrelor and Clopidogrel in Acute Coronary Syndrome: a Comprehensive Meta-Analysis Front Cardiovasc Med 74 93-8

[3] Budaj A(2019)Is ticagrelor worth its high cost and side-effects? Acta Cardiol 9 e015990-70

[4] Cannon CP(2022)Ticagrelor vs. Clopidogrel in older patients with Acute Coronary Syndrome undergoing percutaneous coronary intervention: insights from a Real-World Registry Front Cardiovasc Med 129 463-90

[5] Emanuelsson H(2020)Ticagrelor is not superior to clopidogrel in patients with acute coronary syndromes undergoing pci: a report from Swedish coronary angiography and angioplasty registry J Am Heart Assoc 13 1880-37

[6] Held C(2014)Relationship between intravascular ultrasound guidance and clinical outcomes after drug-eluting stents: the assessment of dual antiplatelet therapy with drug-eluting stents (ADAPT-DES) study Circulation 11 e023481-70

[7] Sun M(2020)Long-term outcomes of coronary stenting with and without Use of Intravascular Ultrasound JACC Cardiovasc Interv 72 3126-47

[8] Cui W(2022)Role of Intravascular Ultrasound-guided percutaneous coronary intervention in optimizing outcomes in Acute Myocardial Infarction J Am Heart Assoc 62 1563-64

[9] Li L(2018)Intravascular Ultrasound Versus Angiography-guided drug-eluting stent implantation: the ULTIMATE Trial J Am Coll Cardiol 123 2736-367

[10] Guerbaai RA(2013)Consideration of a new definition of clinically relevant Myocardial Infarction after coronary revascularization: an expert consensus document from the Society for Cardiovascular Angiography and interventions (SCAI) J Am Coll Cardiol 31 2755-165